ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank7
3Y CAGR-13.3%
5Y CAGR-6.1%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-13.3%/yr
vs -3.9%/yr prior
5Y CAGR
-6.1%/yr
Recent deceleration
Acceleration
-9.5pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.84 | -27.1% |
| 2024 | 2.52 | +16.0% |
| 2023 | 2.17 | -23.0% |
| 2022 | 2.82 | -20.6% |
| 2021 | 3.55 | +40.9% |
| 2020 | 2.52 | -39.0% |
| 2019 | 4.13 | +25.1% |
| 2018 | 3.30 | -36.1% |
| 2017 | 5.17 | -15.5% |
| 2016 | 6.12 | - |